Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced

F Sam1, D B Sawyer, Z Xie

  • 1Cardiovascular Medicine Section, Department of Medicine, Boston University Medical Center, Boston, MA 02118, USA.

Circulation Research
|August 18, 2001
PubMed

Insights

Inducible nitric oxide synthase (NOS2) does not impact early heart attack remodeling. However, NOS2 contributes to reduced heart function and increased cell death in later stages, affecting survival after myocardial infarction.

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Pathophysiology

Background:

  • Inducible nitric oxide synthase (NOS2) is linked to chronic myocardial remodeling and failure.
  • Understanding NOS2's role in post-myocardial infarction (MI) cardiac remodeling is crucial.

Purpose of the Study:

  • To investigate the role of NOS2 in left ventricular (LV) remodeling at early (1 month) and late (4 months) stages after MI.
  • To determine the impact of NOS2 deficiency on cardiac function, apoptosis, and survival post-MI.

Main Methods:

  • Utilized NOS2 knockout (KO) and wild-type (WT) mice subjected to myocardial infarction.
  • Assessed infarct size, LV pressure-volume relationships, and myocyte apoptosis (TUNEL assay).
  • Monitored survival rates in KO and WT mice post-MI.

Main Results:

  • Infarct size and early LV remodeling (1 month) were similar between NOS2 KO and WT mice.
  • Late remodeling (4 months) showed preserved LV developed pressure and reduced myocyte apoptosis in NOS2 KO mice compared to WT.
  • NOS2 deficiency in the late phase was associated with improved cardiac function and reduced mortality.

Conclusions:

  • NOS2 is not critical for infarct size determination or early LV remodeling post-MI.
  • During late remodeling (4 months post-MI), NOS2 in remote myocardium impairs contractile function, increases myocyte apoptosis, and reduces survival.

Related Concept Videos